These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15245704)

  • 1. Metabolic bone disease and parenteral nutrition.
    Hamilton C; Seidner DL
    Curr Gastroenterol Rep; 2004 Aug; 6(4):335-41. PubMed ID: 15245704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the relationship between parenteral nutrition and metabolic bone disease.
    Ferrone M; Geraci M
    Nutr Clin Pract; 2007 Jun; 22(3):329-39. PubMed ID: 17507733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Aluminum Concentrations in Pediatric Patients Receiving Long-Term Parenteral Nutrition.
    Courtney-Martin G; Kosar C; Campbell A; Avitzur Y; Wales PW; Steinberg K; Harrison D; Chambers K
    JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):578-85. PubMed ID: 24743391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does long-term parenteral nutrition impact the bone mineral status of children with intestinal failure?
    Diamanti A; Bizzarri C; Basso MS; Gambarara M; Cappa M; Daniele A; Noto C; Castro M
    J Bone Miner Metab; 2010 May; 28(3):351-8. PubMed ID: 20033239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral nutrition-associated metabolic bone disease.
    Seidner DL
    JPEN J Parenter Enteral Nutr; 2002; 26(5 Suppl):S37-42. PubMed ID: 12216719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Bone Disease in Children with Intestinal Failure and Long-Term Parenteral Nutrition: A Systematic Review.
    Gatti S; Quattrini S; Palpacelli A; Catassi GN; Lionetti ME; Catassi C
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased bone turnover markers in children on long-term parenteral nutrition (PN) for intestinal failure (IF).
    Derepas C; Kosar C; Avitzur Y; Wales PW; Courtney-Martin G
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):85-94. PubMed ID: 23976773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone disease associated with total parenteral nutrition.
    Klein GL; Targoff CM; Ament ME; Sherrard DJ; Bluestone R; Young JH; Norman AW; Coburn JW
    Lancet; 1980 Nov; 2(8203):1041-4. PubMed ID: 6107676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11.
    Hartl WH; Jauch KW; Parhofer K; Rittler P;
    Ger Med Sci; 2009 Nov; 7():Doc17. PubMed ID: 20049074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term parenteral nutrition and metabolic bone disease.
    Hurley DL; McMahon MM
    Endocrinol Metab Clin North Am; 1990 Mar; 19(1):113-31. PubMed ID: 2113469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic bone diseases during long-term total parenteral nutrition.
    Acca M; Ragno A; Francucci CM; D'Erasmo E
    J Endocrinol Invest; 2007; 30(6 Suppl):54-9. PubMed ID: 17721075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-lactate and metabolic bone disease in patients receiving long-term parenteral nutrition.
    Karton MA; Rettmer R; Lipkin EW; Ott SM; Chait A
    JPEN J Parenter Enteral Nutr; 1989; 13(2):132-5. PubMed ID: 2496243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of metabolic bone disease is increased both during and after weaning off parenteral nutrition in pediatric intestinal failure.
    Mutanen A; Mäkitie O; Pakarinen MP
    Horm Res Paediatr; 2013; 79(4):227-35. PubMed ID: 23636002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric intestinal failure: Predictors of metabolic bone disease.
    Demehri FR; Simha S; Stephens L; Harris MB; Arnold MA; Brown PI; Teitelbaum DH
    J Pediatr Surg; 2015 Jun; 50(6):958-62. PubMed ID: 25888275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal failure-associated metabolic bone diseases and response to teriparatide.
    Pazianas M; Compher C; Schiavone-Gatto P; Kinosian BP
    Nutr Clin Pract; 2006 Dec; 21(6):605-9. PubMed ID: 17119166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic bone disease in patients receiving long-term total parenteral nutrition.
    Shike M; Harrison JE; Sturtridge WC; Tam CS; Bobechko PE; Jones G; Murray TM; Jeejeebhoy KN
    Ann Intern Med; 1980 Mar; 92(3):343-50. PubMed ID: 6766694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic bone diseases in intestinal failure.
    Allan PJ; Lal S
    J Hum Nutr Diet; 2020 Jun; 33(3):423-430. PubMed ID: 31823437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transversal study on the prevalence of Metabolic Bone Disease (MBD) and Home Parenteral Nutrition (HPN) in Spain: data from NADYA group].
    Martínez C; Virgili N; Cuerda C; Chicharro L; Gómez P; Moreno JM; Álvarez J; Martí E; Matía P; Penacho MA; Garde C; De Luis D; Gonzalo M; Lobo G;
    Nutr Hosp; 2010; 25(6):920-4. PubMed ID: 21519761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease.
    Shike M; Sturtridge WC; Tam CS; Harrison JE; Jones G; Murray TM; Husdan H; Whitwell J; Wilson DR; Jeejeebhoy KN
    Ann Intern Med; 1981 Nov; 95(5):560-8. PubMed ID: 6794407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When Is Parenteral Nutrition Appropriate?
    Worthington P; Balint J; Bechtold M; Bingham A; Chan LN; Durfee S; Jevenn AK; Malone A; Mascarenhas M; Robinson DT; Holcombe B
    JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):324-377. PubMed ID: 28333597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.